Theravance Biopharma Aktie
13,90
EUR
+0,30
EUR
+2,21
%
16,02
USD
+0,18
USD
+1,10
%
Werbung
Theravance Biopharma Aktie Analyse
| 16.06.17 | Theravance Biopharma Overweight | Cantor Fitzgerald | |
| 11.05.17 | Theravance Biopharma Buy | Needham & Company, LLC | |
| 21.12.16 | Theravance Biopharma Buy | Needham & Company, LLC |
Werbung
Werbung